GlobeNewswire

Calidi Biotherapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
13/11/2026
- Continued to advance the development of CLD-401 towards the clinic - Presented new CLD-401 data and in situ TCE platform advances at the ESMO Congress 2026 - Received $1.2 million gross proceeds from at-the-market [...]
BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026
FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA) Strategic transaction with [...]
Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress
13/11/2026
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted [...]
Eclipse Energy and Weatherford Demonstrate Subsurface Hydrogen Migration Between Wells in the Permian
13/11/2026
Hydrogen generated underground was recovered in multiple wells and moved through existing commercial infrastructure HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Eclipse Energy, a Houston-based energy technology company [...]
Novartis receives positive CHMP opinion for Cosentyx® in adolescents aged 12+ with hidradenitis suppurativa (HS)
13/11/2026
If approved, Cosentyx ® (secukinumab) will become the only IL-17A inhibitor for adolescents with moderate to severe HS in Europe 1,2 HS affects as many as one in 100 people worldwide, 3 with more than half developing [...]
CORRECTION -- Park Dental Partners Announces Third Quarter 2026 Results
13/11/2026
This press release corrects the “Percent Change (At Midpoint)” in the outlook table contained in the Company's press release originally issued on November 12, 2026. The corrected table is included herein. There were no [...]
NACHC Returns to HLTH 2026 to Showcase How Community Health Centers are Scaling Innovation
13/11/2026
Bethesda, Nov. 13, 2026 (GLOBE NEWSWIRE) -- BETHESDA, Md. – November 13, 2026 – The National Association of Community Health Centers (NACHC) is returning to the 2026 HLTH USA conference . As the voice of the nation’s 1, [...]
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
13/11/2026
Press release – No. 24 / 2026 Zealand Pharma announces EU approval of Zeydovio TM (glepaglutide) for the treatment of short bowel syndrome The approval marks the first major advancement in short bowel syndrome treatment [...]
CUKTECH Makes MPL Malaysia S18 Playoffs Debut to Champion Reliable Power and Peak Performance in Esports
13/11/2026
KUALA LUMPUR, Nov. 13, 2026 (GLOBE NEWSWIRE) -- CUKTECH made its debut at the Mobile Legends: Bang Bang (MLBB) Professional League (MPL) Malaysia Season 18 Playoffs as the league's Strategic Partner for the Powerbank [...]
RAMSAY GENERALE DE SANTE : ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026
13/11/2026
INFORMATION REGLEMENTAIRE Paris, le 13 novembre 2026 ASSEMBLEE GENERALE MIXTE DU 4 DECEMBRE 2026 Convocation de l’Assemblée Générale Mixte de Ramsay Générale de Santé Modalités de mise à disposition ou de consultation [...]
RAMSAY GENERALE DE SANTE : COMBINED GENERAL MEETING OF DECEMBER 4, 2026
13/11/2026
REGULATORY INFORMATION Paris, 13 November 2026 COMBINED GENERAL MEETING OF DECEMBER 4, 2026 Convening of the Ramsay Générale de Santé General Meeting Conditions of availability and consultation of the preparatory [...]
FREHEMGO® (denecimig) approved in the EU for haemophilia A, with a choice of monthly, every-two-weeks or weekly dosing
13/11/2026
European Commission (EC) grants marketing authorisation for FREHEMGO® (denecimig) for haemophilia A (congenital FVIII deficiency), with or without inhibitors, in adults and children. FREHEMGO® is the first FVIIIa [...]
XORTX Patent Allowed for XRx-101 Program by Japan Patent Office
13/11/2026
Japan Patent Office allows claims directed to xanthine oxidase inhibitor compositions for acute kidney injury and other health consequences of viral infection; once registered, patent expected to remain in force until [...]
HealthEx Joins Sierra’s Personal Agent Protocol as a Design Partner
13/11/2026
HealthEx will help shape how personal AI agents work with healthcare organizations, bringing experience in verified identity, consent, and personal health context SAN FRANCISCO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- [...]
Oncolytics Biotech® Announces Clinical Supply Agreement to Evaluate Pelareorep in Combination with LOQTORZI® (toripalimab-tpzi) in SCAC
13/11/2026
Pelareorep and toripalimab combine potentially complementary mechanisms designed to enhance antitumor immune responses and help overcome tumor immune resistance Study may represent a first step toward evaluating the [...]
Pennant Group to Participate in the 2026 Stephens Annual Investment Conference
13/11/2026
EAGLE, Idaho, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Kura Oncology to Participate in Two Investor Conferences in November
13/11/2026
SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a biopharmaceutical company focused on precision medicines for the treatment of cancer, today announced that management will present at [...]
From the Fire Service to Counselling; Guelph Clinic Brings Community Experience into Psychotherapy
13/11/2026
Trickett Psychotherapy welcomes four practitioners with backgrounds in addiction support, emergency response, vocational counselling and corporate life, alongside a holiday initiative to make a first session more [...]
Jade Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
13/11/2026
JADE101 Phase 3 registrational trial in IgA nephropathy (EVERGREEN) expected to initiate in the fourth quarter of 2026 JADE101 Phase 2 clinical trial in IgA nephropathy (JUNIPER) ongoing; interim data expected in the [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum